63 related articles for article (PubMed ID: 21215541)
21. Role of dynamic contrast-enhanced magnetic resonance (MR) imaging and proton MR spectroscopic imaging in the detection of local recurrence after radical prostatectomy for prostate cancer.
Sciarra A; Panebianco V; Salciccia S; Osimani M; Lisi D; Ciccariello M; Passariello R; Di Silverio F; Gentile V
Eur Urol; 2008 Sep; 54(3):589-600. PubMed ID: 18226441
[TBL] [Abstract][Full Text] [Related]
22. In the assessment of supratentorial glioma grade: the combined role of multivoxel proton MR spectroscopy and diffusion tensor imaging.
Zou QG; Xu HB; Liu F; Guo W; Kong XC; Wu Y
Clin Radiol; 2011 Oct; 66(10):953-60. PubMed ID: 21663899
[TBL] [Abstract][Full Text] [Related]
23. MR imaging of the prostate at 3.0T with external phased array coil - preliminary results.
Morakkabati-Spitz N; Bastian PJ; Gieseke J; Träber F; Kuhl CK; Wattjes MP; Müller SC; Schild HH
Eur J Med Res; 2008 Jun; 13(6):287-91. PubMed ID: 18558555
[TBL] [Abstract][Full Text] [Related]
24. Predictors of prostate cancer evaluated by receiver operating characteristics partial area index: a prospective institutional study.
Gjengstø P; Paus E; Halvorsen OJ; Eide J; Akslen LA; Wentzel-Larsen T; Hoisaeter PA
J Urol; 2005 Feb; 173(2):425-8. PubMed ID: 15643193
[TBL] [Abstract][Full Text] [Related]
25. The combination of multi-voxel MR spectroscopy with MR imaging improve the diagnostic accuracy for localization of prostate cancer.
Hasumi M; Suzuki K; Taketomi A; Matsui H; Yamamoto T; Ito K; Kurokawa K; Aoki J; Endo K; Yamanaka H
Anticancer Res; 2003; 23(5b):4223-7. PubMed ID: 14666629
[TBL] [Abstract][Full Text] [Related]
26. Role of magnetic resonance imaging before initial biopsy: comparison of magnetic resonance imaging-targeted and systematic biopsy for significant prostate cancer detection.
Haffner J; Lemaitre L; Puech P; Haber GP; Leroy X; Jones JS; Villers A
BJU Int; 2011 Oct; 108(8 Pt 2):E171-8. PubMed ID: 21426475
[TBL] [Abstract][Full Text] [Related]
27. Prostate cancer detection with multi-parametric MRI: logistic regression analysis of quantitative T2, diffusion-weighted imaging, and dynamic contrast-enhanced MRI.
Langer DL; van der Kwast TH; Evans AJ; Trachtenberg J; Wilson BC; Haider MA
J Magn Reson Imaging; 2009 Aug; 30(2):327-34. PubMed ID: 19629981
[TBL] [Abstract][Full Text] [Related]
28. Comparison of qualitative and quantitative measurements on unenhanced T1-weighted fat saturation MR images in predicting pancreatic pathology.
Gallix BP; Bret PM; Atri M; Lecesne R; Reinhold C
J Magn Reson Imaging; 2005 May; 21(5):583-9. PubMed ID: 15834922
[TBL] [Abstract][Full Text] [Related]
29. Citrate as an in vivo marker to discriminate prostate cancer from benign prostatic hyperplasia and normal prostate peripheral zone: detection via localized proton spectroscopy.
Kurhanewicz J; Vigneron DB; Nelson SJ; Hricak H; MacDonald JM; Konety B; Narayan P
Urology; 1995 Mar; 45(3):459-66. PubMed ID: 7533458
[TBL] [Abstract][Full Text] [Related]
30. Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer.
Yoshizako T; Wada A; Hayashi T; Uchida K; Sumura M; Uchida N; Kitagaki H; Igawa M
Acta Radiol; 2008 Dec; 49(10):1207-13. PubMed ID: 19031184
[TBL] [Abstract][Full Text] [Related]
31. Endorectal magnetic resonance imaging and magnetic resonance spectroscopy to monitor the prostate for residual disease or local cancer recurrence after transrectal high-intensity focused ultrasound.
Cirillo S; Petracchini M; D'Urso L; Dellamonica P; Illing R; Regge D; Muto G
BJU Int; 2008 Aug; 102(4):452-8. PubMed ID: 18476973
[TBL] [Abstract][Full Text] [Related]
32. The performance of prostate specific antigen, prostate specific antigen density and transition zone density in the era of extended biopsy schemes.
Elliott CS; Shinghal R; Presti JC
J Urol; 2008 May; 179(5):1756-61; discussion 1761. PubMed ID: 18343425
[TBL] [Abstract][Full Text] [Related]
33. Diagnosis of prostate cancer in patients with persistently elevated PSA and tumor-negative biopsy in ambulatory care: performance of MR imaging in a multi-reader environment.
Scheidler J; Weöres I; Brinkschmidt C; Zeitler H; Panzer S; Scharf M; Heuck A; Siebels M
Rofo; 2012 Feb; 184(2):130-5. PubMed ID: 22274854
[TBL] [Abstract][Full Text] [Related]
34. Malignancy assessment of brain tumours with magnetic resonance spectroscopy and dynamic susceptibility contrast MRI.
Fayed N; Dávila J; Medrano J; Olmos S
Eur J Radiol; 2008 Sep; 67(3):427-33. PubMed ID: 18442889
[TBL] [Abstract][Full Text] [Related]
35. Ability to predict biochemical progression using Gleason score and a computer-generated quantitative nuclear grade derived from cancer cell nuclei.
Veltri RW; Miller MC; Partin AW; Coffey DS; Epstein JI
Urology; 1996 Nov; 48(5):685-91. PubMed ID: 8911509
[TBL] [Abstract][Full Text] [Related]
36. Multigene methylation analysis for detection and staging of prostate cancer.
Enokida H; Shiina H; Urakami S; Igawa M; Ogishima T; Li LC; Kawahara M; Nakagawa M; Kane CJ; Carroll PR; Dahiya R
Clin Cancer Res; 2005 Sep; 11(18):6582-8. PubMed ID: 16166436
[TBL] [Abstract][Full Text] [Related]
37. Diffusion-weighted MR imaging for the evaluation of seminal vesicle invasion in prostate cancer: initial results.
Kim CK; Choi D; Park BK; Kwon GY; Lim HK
J Magn Reson Imaging; 2008 Oct; 28(4):963-9. PubMed ID: 18821631
[TBL] [Abstract][Full Text] [Related]
38. Ability to predict metastasis based on pathology findings and alterations in nuclear structure of normal-appearing and cancer peripheral zone epithelium in the prostate.
Veltri RW; Khan MA; Miller MC; Epstein JI; Mangold LA; Walsh PC; Partin AW
Clin Cancer Res; 2004 May; 10(10):3465-73. PubMed ID: 15161703
[TBL] [Abstract][Full Text] [Related]
39. Extended 21-sample needle biopsy protocol for diagnosis of prostate cancer in 1000 consecutive patients.
Guichard G; Larré S; Gallina A; Lazar A; Faucon H; Chemama S; Allory Y; Patard JJ; Vordos D; Hoznek A; Yiou R; Salomon L; Abbou CC; de la Taille A
Eur Urol; 2007 Aug; 52(2):430-5. PubMed ID: 17412489
[TBL] [Abstract][Full Text] [Related]
40. Differentiation between intra-axial metastatic tumor progression and radiation injury following fractionated radiation therapy or stereotactic radiosurgery using MR spectroscopy, perfusion MR imaging or volume progression modeling.
Huang J; Wang AM; Shetty A; Maitz AH; Yan D; Doyle D; Richey K; Park S; Pieper DR; Chen PY; Grills IS
Magn Reson Imaging; 2011 Sep; 29(7):993-1001. PubMed ID: 21571478
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]